NASDAQ:OVAS - OvaScience Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$9.60
▼ -0.6 (-5.88%)
Get New OvaScience Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OVAS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OVAS

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for OvaScience in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $9.60.

This chart shows the closing price for OVAS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in OvaScience. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/1/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/30/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/16/2018HC WainwrightReiterated RatingBuy$15.00High
11/6/2017HC WainwrightReiterated RatingBuy$15.00N/A
8/3/2017OppenheimerReiterated RatingHoldLow
6/22/2017OppenheimerReiterated RatingHoldHigh
5/12/2017HC WainwrightReiterated RatingBuy$15.00Low
4/18/2017Credit Suisse GroupReiterated RatingUnderperform ➝ Underperform$1.00Low
3/22/2017OppenheimerReiterated RatingHoldMedium
3/4/2017OppenheimerReiterated RatingHoldN/A
12/25/2016OppenheimerReiterated RatingHoldN/A
12/6/2016OppenheimerReiterated RatingHoldN/A
(Data available from 11/27/2016 forward)

News Sentiment Rating

0.92 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/30/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/29/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2021

Current Sentiment

  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
OvaScience logo
Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI.
Read More

Today's Range

Now: $9.60
Low: $9.47
High: $10.20

50 Day Range

MA: $12.74
Low: $8.56
High: $17.10

52 Week Range

Now: $9.60
Low: $0.66
High: $1.52

Volume

10,266 shs

Average Volume

163,131 shs

Market Capitalization

$343.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.11

Frequently Asked Questions

What sell-side analysts currently cover shares of OvaScience?

The following sell-side analysts have issued research reports on OvaScience in the last twelve months:
View the latest analyst ratings for OVAS.

What is the current price target for OvaScience?

0 Wall Street analysts have set twelve-month price targets for OvaScience in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for OvaScience in the next year.
View the latest price targets for OVAS.

What is the current consensus analyst rating for OvaScience?

OvaScience currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for OVAS.

How do I contact OvaScience's investor relations team?

OvaScience's physical mailing address is 9 FOURTH AVENUE, WALTHAM MA, 02451. The biotechnology company's listed phone number is (734) 845-9000 and its investor relations email address is [email protected] The official website for OvaScience is www.ovascience.com.